Male-specific protein disulphide isomerase function is essential for plasmodium transmission and a vulnerable target for intervention
File(s)MaleSpecificProteinDisulphideIsomeraseFunction.pdf (1.49 MB)
Published version
Author(s)
Angrisano, Fiona
Sala, Katarzyna
Tapanelli, Sofia
Christophides, George
Blagborough, Andrew
Type
Journal Article
Abstract
Inhibiting transmission of Plasmodium is an essential strategy in malaria eradication, and the biological process of gamete fusion during fertilization is a proven target for this approach. Lack of knowledge of the mechanisms underlying fertilization have been a hindrance in the development of transmission-blocking interventions. Here we describe a protein disulphide isomerase essential for malarial transmission (PDI-Trans/PBANKA_0820300) to the mosquito. We show that PDI-Trans activity is male-specific, surface-expressed, essential for fertilization/transmission, and exhibits disulphide isomerase activity which is up-regulated post-gamete activation. We demonstrate that PDI-Trans is a viable anti-malarial drug and vaccine target blocking malarial transmission with the use of PDI inhibitor bacitracin (98.21%/92.48% reduction in intensity/prevalence), and anti-PDI-Trans antibodies (66.22%/33.16% reduction in intensity/prevalence). To our knowledge, these results provide the first evidence that PDI function is essential for malarial transmission, and emphasize the potential of anti-PDI agents to act as anti-malarials, facilitating the future development of novel transmission-blocking interventions.
Date Issued
2019-12-04
Date Acceptance
2019-11-11
Citation
Scientific Reports, 2019, 9 (1)
ISSN
2045-2322
Publisher
Nature Publishing Group
Journal / Book Title
Scientific Reports
Volume
9
Issue
1
Copyright Statement
© The Author(s) 2019. Open Access. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Sponsor
Medical Research Council (MRC)
Bill & Melinda Gates Foundation
Bill & Melinda Gates Foundation
Grant Number
MR/N00227X/1
n/a
OPP1158151
Subjects
Science & Technology
Multidisciplinary Sciences
Science & Technology - Other Topics
BLOCKING IMMUNITY
SURFACE PROTEIN
GAMETE FUSION
PDI FAMILY
MALARIA
HAP2
BERGHEI
KINASE
IMMUNIZATION
CANDIDATES
0601 Biochemistry and Cell Biology
0299 Other Physical Sciences
Publication Status
Published
Article Number
18300